Hepatic stellate cells specific liposomes with the Toll‐like receptor 4 shRNA attenuates liver fibrosis-Reference-Cited by-同舟云学术

Hepatic stellate cells specific liposomes with the Toll‐like receptor 4 shRNA attenuates liver fibrosis

Published:2020-12-18 Issue:2 Volume:25 Page:1299-1313
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Zhang Yuwei¹,Li Yang¹,Mu Tong¹,Tong Nanwei¹,Cheng Ping²^ORCID

Affiliation:

1. Division of Endocrinology and Metabolism State Key Laboratory of Biotherapy West China HospitalSichuan University, and Collaborative Innovation Center for Biotherapy Chengdu China

2. State Key Laboratory of Biotherapy and Cancer Center West China HospitalSichuan University, and Collaborative Innovation Center for Biotherapy Chengdu China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.16209

Reference53 articles.

1. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

2. Liver Fibrosis: From Pathogenesis to Novel Therapies

3. Pathophysiologie der Leberfibrose

4. Modulation of hepatic stellate cells and reversibility of hepatic fibrosis

5. Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The circAno6/miR-296-3p/TLR4 signaling axis mediates the inflammatory response to induce the activation of hepatic stellate cells;Gene;2024-08

2. Toll-like receptor 5 tunes hepatic and pancreatic stellate cells activation;BMJ Open Gastroenterology;2023-07

3. Mechanism of thymosin β4 in ameliorating liver fibrosis via the MAPK/NF‐κB pathway;Journal of Biochemical and Molecular Toxicology;2023-05-21

4. Pattern recognition receptors in the development of nonalcoholic fatty liver disease and progression to hepatocellular carcinoma: An emerging therapeutic strategy;Frontiers in Endocrinology;2023-03-20

5. Insights on drug and gene delivery systems in liver fibrosis;Asian Journal of Pharmaceutical Sciences;2023-03